Healthcare

Disposable Endoscopes Market worth $2.67 billion by 2030 with 22.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 31, 2025, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025

FRANKFURT, Germany, Oct. 31, 2025, 07:22 GMT-04

Kexing-Biopharm

Read full article →

Agriculture Biotechnology Market worth $144.25 billion by 2030- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 31, 2025, 06:30 GMT-04

MARKETSANDMARKETS

Read full article →

Vesper Bio announces positive Phase Ib/IIa topline results for lead candidate VES001 for frontotemporal degeneration

COPENHAGEN, Denmark, Oct. 31, 2025, 04:00 GMT-04

VESPER-BIO

Read full article →

Atypical Teratoid/Rhabdoid Tumor Treatment Market Shows Promising CAGR During the Forecast Period (2025-2034) with Growing Clinical Trials and R&D Initiatives | DelveInsight

LAS VEGAS, Oct. 30, 2025, 17:31 GMT-04

DELVEINSIGHT

Read full article →

Thyroid Function Test Market to Reach USD 7,289.26 million by 2032, Growing At An 6.31% CAGR - Credence Research

PUNE, India, Oct. 30, 2025, 15:20 GMT-04

Credence-Research

Read full article →

Cardiovascular, Renal & Metabolic (CRM) Diseases Market to Reach USD 451.87 Billion by 2033, Driven by Rising Burden of Chronic Conditions | DataM Intelligence

AUSTIN, Texas and TOKYO, Oct. 30, 2025, 10:35 GMT-04

DATAM-INTELLIGENCE

Read full article →

Cystic Fibrosis (CF) Therapeutics Market to Reach $17.1 billion by 2027 in the short term and $32.3 billion by 2034 Globally, at 9.6% CAGR: Allied Market Research

PORTLAND, Ore., Oct. 30, 2025, 10:30 GMT-04

ALLIED-MARKET-RESEARC

Read full article →

Intraoperative Radiation Therapy Market to Double by 2030 Driven by Precision Oncology and Growing Cancer Incidence | DataM Intelligence

AUSTIN, Texas and TOKYO, Oct. 30, 2025, 06:50 GMT-04

DATAM-INTELLIGENCE

Read full article →

Sales of Leqembi® totaled 18 billion yen in the third quarter 2025

STOCKHOLM, Oct. 30, 2025, 06:33 GMT-04

BIOARCTIC-SALES

Read full article →

Alys Pharmaceuticals doses first subject in Phase 1/1b trial of ALY-301, a first-in-class mast cell selective c-Kit inhibitor for Chronic Urticaria

BOSTON and LAUSANNE, Switzerland, Oct. 30, 2025, 04:30 GMT-04

Alys-CellStudy

Read full article →

Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities

MUMBAI, India, Oct. 30, 2025, 01:21 GMT-04

Piramal-IntoCell

Read full article →

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025, 21:00 GMT-04

Arkbio-Clinical-Trial

Read full article →

Postoperative Ileus Market to Advance Moderately During the Forecast Period (2025-2034) Owing to the Launch of Novel Therapies | DelveInsight

LAS VEGAS, Oct. 29, 2025, 17:31 GMT-04

DelveInsight-Business

Read full article →

Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An 7.85% CAGR - Credence Research

PUNE, India, Oct. 29, 2025, 14:59 GMT-04

Credence-Research

Read full article →

Clinical Analytics Market worth $81.32 billion by 2030 with 19.7% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 29, 2025, 10:15 GMT-04

MARKETSANDMARKETS

Read full article →

VentureMed Group Closes $28M Series C Funding to Accelerate Commercial Adoption and Expand Indications for the FLEX VPTM System

MINNEAPOLIS, Oct. 29, 2025, 10:00 GMT-04

VentureMed-FLEX-FLEX

Read full article →

Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability

NEW YORK, Oct. 29, 2025, 08:30 GMT-04

NetworkNewsWire

Read full article →

Grupo Elfa and NUPCO sign agreement to support Saudi healthcare ecosystem with high-quality medical innovation and AI expertise

RIYADH, Saudi Arabia, Oct. 29, 2025, 08:07 GMT-04

Grupo-Elfa-NUPCO

Read full article →

PARTNERSHIP OMRON HEALTHCARE UK & STROKE ASSOCIATION: Stroke Association and OMRON Healthcare UK Partner to Raise Awareness of Stroke Risk and Atrial Fibrillation

KYOTO, Japan, Oct. 29, 2025, 04:00 GMT-04

OMRON-Healthcare

Read full article →